August 2016 - BriaCell

BriaCell Closes Oversubscribed Non-Brokered Private Placement

August 19, 2016

BERKELEY, CALIFORNIA and VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug. 19, 2016) – BriaCell Therapeutics Corp. (“BriaCell” ...

BriaCell Appoints the Lead Principal Investigator and First Clinical Site for its Upcoming Phase I/IIa Clinical Trial in Advanced Breast Cancer

August 17, 2016

– Dr. Jarrod P. Holmes, a prominent breast cancer vaccine expert to lead the study ...

BriaCell Announces Non-Brokered Private Placement

August 12, 2016

BriaCell Therapeutics Corp. (OTCQB:BCTXF)(TSX VENTURE:BCT) (“BriaCell”, the “Company”, or “BCT”) announced today that it intends ...